Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cassava Sciences, Inc. - Common Stock (NQ: SAVA )

2.610 -0.090 (-3.34%)
Streaming Delayed Price Updated: 2:24 PM EST, Feb 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
36 37 Next >
Cassava Sciences Stock Is Still Risky but Has Plenty of Upside Potential
Among the plethora of high-risk, speculative, clinical-stage biotech plays out there, SAVA stock is one of the better bets out there. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our... 
Via Benzinga
Peering Into Cassava Sciences Inc's Recent Short Interest
Cassava Sciences Inc's (NASDAQ:SAVA) short percent of float has risen 22.31% since last its last report. The company recently reported that it has 10.25 million shares sold short... 
Via Benzinga
Cassava Sciences Stock Is Worth Almost 4x More After Adjusting for Risk
Cassava Sciences stands to gain using probability methods. On a risk-adjusted basis, SAVA stock is worth 3.7 times more, despite its downside. 
Via InvestorPlace
7 High Risk Stocks That Are Worth The Volatile Vibes
These seven high risk stocks made wild moves in 2021, but still have the potential to rocket higher. All are full of both risk and reward. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our... 
Via Benzinga
Global Alzheimer’s Disease Therapeutics Market Projected To Generate Revenue Of $9.97 Billion By 2028
Palm Beach, FL –January 4, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease is a degenerative, progressive ailment that attacks the brain’s nerve cells, resulting in memory loss,... 
Via FinancialNewsMedia
Exposures COVID-19
How Are The Shorts Feeling About Cassava Sciences Inc?
Cassava Sciences Inc's (NASDAQ:SAVA) short interest has increased 22% since the last report. The company recently reported that it has 10 million shares sold short, which is... 
Via Benzinga
7 of the Best Meme Stocks for 2022 to Buy Now
Although the meme stocks phenomenon is sagging in popularity, these seven current and/or former Reddit favorites could make another "to the moon" move or two in 2022. 
Via InvestorPlace
Cassava Sciences Whale Trades Spotted
A whale with a lot of money to spend has taken a noticeably bearish stance on Cassava Sciences. Looking at options history for Cassava Sciences (NASDAQ:SAVA) we detected 12... 
Via Benzinga
Investing In This Alzheimer’s Drug Maker Risky But Could Be Quite Rewarding
Coming up with the medicine for Alzheimer's Disease can be really good for a company and although it might seem risky, with great risks come great rewards. 
Via Talk Markets
(SAVA) - Analyzing Cassava Sciences Inc's Short Interest
Cassava Sciences Inc's (NASDAQ:SAVA) short percent of float has fallen 26.17% since last its last report. The company recently reported that it has 8.38 million shares sold short... 
Via Benzinga
NAKD Stock: Is the Naked Brand Reverse Stock Split Good or Bad? What Investors Are Saying
Naked Brand (NAKD) stock is in the news today as investors react to the company's 15-for-one reverse stock split for Tuesday. 
Via InvestorPlace
Here's How Much $1000 Invested In Cassava Sciences 5 Years Ago Would Be Worth Today
Cassava Sciences (NASDAQ:SAVA) has outperformed the market over the past 5 years by 41.64% on an annualized basis. Buying $1,000 In SAVA: 5 years ago, an investor could have... 
Via Benzinga
55 Biggest Movers From Yesterday
Gainers Reliance Global Group, Inc. (NASDAQ: RELI) shares jumped 78.7% to close at $5.45 on Tuesday after gaining around 6% on Monday. Biofrontera Inc. (NASDAQ: BFRI) gained 44.8... 
Via Benzinga
SAVA Stock Alert: What Is Going on With Red-Hot Cassava Sciences Today?
Biotech company Cassava saw a big jump today on positive news related to its Alzheimer's disease treatment. Keep an eye on SAVA stock. 
Via InvestorPlace
Science Journal Finds No Evidence To Data Manipulation By Cassava Sciences' In 2005 Publication
Cassava Sciences Inc (NASDAQ: SAVA) has been informed by the Neuroscience journal that there is no evidence to support claims of data manipulation in a 2005 paper authored by... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Jaguar Health (NASDAQ:JAGX) shares increased by 58.26% to $1.82 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 28.4... 
Via Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
Gainers Reliance Global Group, Inc. (NASDAQ: RELI) surged 126% to $6.91 after gaining around 6% on Monday. Biofrontera Inc. (NASDAQ: BFRI) climbed 71.4% to $13.06 after gaining... 
Via Benzinga
BRZE Stock: 16 Reasons Why Newly Public Braze Is Bouncing Higher Today
Braze (BRZE) stock is on the move Tuesday after the company released its earnings report for the third quarter of the year. 
Via InvestorPlace
BFRI Stock Alert: The Social Media Chatter That Has Biofrontera Booming Today
Biofrontera (BFRI) stock is on the move today as traders take to Twitter (TWTR) to discuss the latest news surrounding the company. 
Via InvestorPlace
Why Cassava Sciences Stock Is Trading Higher Today
Cassava Sciences Inc (NASDAQ: SAVA) is trading higher Tuesday after the company was informed by Neuroscience journal that there was no evidence to support data manipulation... 
Via Benzinga
SAVA Stock: The Social Media Chatter That Has Cassava Sciences Trending Today
Cassava Sciences (SAVA) stock is getting some extra attention today from traders on social media and we've got all the details. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) stock moved upwards by 75.98% to $4.47 during Tuesday's pre-market session. The company's market cap stands at $62.8... 
Via Benzinga
26 Stocks Moving in Tuesday's Pre-Market Session
Gainers Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) rose 102% to $5.13 in pre-market trading after the company reported pan-coronavirus monoclonal antibody cocktail that retains... 
Via Benzinga
65 Biggest Movers From Yesterday
Gainers Society Pass Incorporated (NASDAQ: SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index. Bluerock... 
Via Benzinga
7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts
These seven drug stocks, a mix of growth, value, and moonshot plays, each stand to see big moves in the next twelve months. 
Via InvestorPlace
Exposures COVID-19
2 Big Stock Bets That Are Insiders Are Buying Now
Reddit users picked their favorite biotech stocks, and all of them have fallen this year. The insiders have a different buying strategy. 
Via InvestorPlace
CORRECTING and REPLACING CASSAVA SCIENCES ALERT: Bragar Eagel & Squire, P.C. Is Investigating Cassava Sciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
CASSAVA SCIENCES ALERT: Bragar Eagel & Squire, P.C. Is Investigating Cassava Sciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
36 37 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.